T2 Biosystems Reports Third Quarter 2017 Financial Results and Provides Company Update
November 02, 2017 16:05 ET
|
T2 Biosystems, Inc.
Submitted 510(k) Application to the FDA Requesting Market Clearance for T2Bacteria PanelYear over Year Quarterly Product Revenue Growth of 27.4% LEXINGTON, Mass., Nov. 02, 2017 (GLOBE NEWSWIRE) --...
T2 Biosystems to Attend the Canaccord Medical Technologies and Diagnostics Forum
November 01, 2017 08:01 ET
|
T2 Biosystems, Inc.
LEXINGTON, Mass., Nov. 01, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) an emerging leader in the development of innovative diagnostic products to improve patient health, today...
T2 Biosystems Announces 2017 Third Quarter Financial and Operational Results Release and Conference Call Date
October 16, 2017 08:00 ET
|
T2 Biosystems, Inc.
LEXINGTON, MA, Oct. 16, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) an emerging leader in the development of innovative diagnostic products to improve patient health, today announced...
Clinicians Discuss Positive Impact of T2MR Platform on Sepsis Care at IDWeek 2017
October 12, 2017 10:44 ET
|
T2 Biosystems, Inc.
LEXINGTON, Mass., Oct. 12, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic products to improve patient health, today...
Study Published in Journal of Antimicrobial Stewardship Shows Patients Diagnosed with T2Candida Panel Treated More Than Eight Times Faster
October 03, 2017 07:00 ET
|
T2 Biosystems, Inc.
LEXINGTON, Mass., Oct. 03, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic products to improve patient health, today...
T2 Biosystems Announces Presentations at IDWeek 2017
September 21, 2017 08:00 ET
|
T2 Biosystems, Inc.
LEXINGTON, Mass., Sept. 21, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic products to improve patient health, today...
T2 Biosystems to Present at the Cantor Fitzgerald Global Healthcare Conference
September 18, 2017 08:00 ET
|
T2 Biosystems, Inc.
LEXINGTON, Mass., Sept. 18, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic products to improve patient health, today...
T2 Biosystems Announces Pricing of Public Offering of Common Stock
September 15, 2017 08:20 ET
|
T2 Biosystems, Inc.
LEXINGTON, Mass., Sept. 15, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) today announced the pricing of an underwritten registered public offering of 4,375,000 shares of common stock...
T2 Biosystems Announces Proposed Public Offering of Common Stock
September 14, 2017 16:11 ET
|
T2 Biosystems, Inc.
LEXINGTON, Mass., Sept. 14, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) today announced that it is commencing an underwritten registered public offering of shares of its common stock....
T2 Biosystems Submits 510(k) Application to the FDA for Review of T2Bacteria Panel
September 11, 2017 08:00 ET
|
T2 Biosystems, Inc.
LEXINGTON, Mass., Sept. 11, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic products to improve patient health, today...